nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2C19—chronic kidney failure	0.498	0.611	CbGaD
Escitalopram—CYP3A4—chronic kidney failure	0.317	0.389	CbGaD
Escitalopram—SLC6A2—sympathetic nervous system—chronic kidney failure	0.00496	0.177	CbGeAlD
Escitalopram—Citalopram—CYP2B6—chronic kidney failure	0.00442	0.433	CrCbGaD
Escitalopram—Citalopram—CYP2C19—chronic kidney failure	0.00267	0.262	CrCbGaD
Escitalopram—CYP2C19—urine—chronic kidney failure	0.00256	0.0914	CbGeAlD
Escitalopram—SLC6A3—nerve—chronic kidney failure	0.00233	0.0831	CbGeAlD
Escitalopram—SLC6A2—nerve—chronic kidney failure	0.00188	0.067	CbGeAlD
Escitalopram—Citalopram—CYP3A4—chronic kidney failure	0.0017	0.166	CrCbGaD
Escitalopram—SLC6A4—blood plasma—chronic kidney failure	0.00161	0.0576	CbGeAlD
Escitalopram—CYP3A4—urine—chronic kidney failure	0.00151	0.0541	CbGeAlD
Escitalopram—CYP2D6—urine—chronic kidney failure	0.00149	0.0532	CbGeAlD
Escitalopram—Citalopram—ABCB1—chronic kidney failure	0.00141	0.139	CrCbGaD
Escitalopram—CYP2C19—blood plasma—chronic kidney failure	0.00134	0.0477	CbGeAlD
Escitalopram—CYP3A4—blood plasma—chronic kidney failure	0.000789	0.0282	CbGeAlD
Escitalopram—CYP2D6—blood plasma—chronic kidney failure	0.000777	0.0278	CbGeAlD
Escitalopram—CHRM1—cardiovascular system—chronic kidney failure	0.000744	0.0266	CbGeAlD
Escitalopram—SLC6A4—digestive system—chronic kidney failure	0.00062	0.0221	CbGeAlD
Escitalopram—ADRA1A—renal system—chronic kidney failure	0.000618	0.0221	CbGeAlD
Escitalopram—ADRA1A—cardiovascular system—chronic kidney failure	0.000611	0.0218	CbGeAlD
Escitalopram—SLC6A2—gonad—chronic kidney failure	0.000596	0.0213	CbGeAlD
Escitalopram—SLC6A4—blood—chronic kidney failure	0.00059	0.0211	CbGeAlD
Escitalopram—CYP2C19—digestive system—chronic kidney failure	0.000513	0.0183	CbGeAlD
Escitalopram—CYP2C19—blood—chronic kidney failure	0.000489	0.0175	CbGeAlD
Escitalopram—ADRA1A—blood—chronic kidney failure	0.000483	0.0173	CbGeAlD
Escitalopram—HRH1—urethra—chronic kidney failure	0.00047	0.0168	CbGeAlD
Escitalopram—HRH1—digestive system—chronic kidney failure	0.000393	0.014	CbGeAlD
Escitalopram—CYP3A4—renal system—chronic kidney failure	0.00037	0.0132	CbGeAlD
Escitalopram—CYP2D6—renal system—chronic kidney failure	0.000364	0.013	CbGeAlD
Escitalopram—CYP3A4—kidney—chronic kidney failure	0.000358	0.0128	CbGeAlD
Escitalopram—CYP2D6—kidney—chronic kidney failure	0.000352	0.0126	CbGeAlD
Escitalopram—CYP3A4—digestive system—chronic kidney failure	0.000304	0.0108	CbGeAlD
Escitalopram—CYP2D6—digestive system—chronic kidney failure	0.000299	0.0107	CbGeAlD
Escitalopram—CYP3A4—blood—chronic kidney failure	0.000289	0.0103	CbGeAlD
Escitalopram—CYP2D6—blood—chronic kidney failure	0.000285	0.0102	CbGeAlD
Escitalopram—CYP2C19—Metabolism—CYP2B6—chronic kidney failure	2.71e-05	0.000184	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PRKAG2—chronic kidney failure	2.71e-05	0.000184	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PRKD1—chronic kidney failure	2.71e-05	0.000184	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AGXT—chronic kidney failure	2.69e-05	0.000183	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GATM—chronic kidney failure	2.69e-05	0.000183	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NCF1—chronic kidney failure	2.69e-05	0.000182	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—EDN1—chronic kidney failure	2.68e-05	0.000182	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGF23—chronic kidney failure	2.68e-05	0.000182	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—EDN1—chronic kidney failure	2.67e-05	0.000182	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGF23—chronic kidney failure	2.67e-05	0.000181	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.67e-05	0.000181	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL5—chronic kidney failure	2.66e-05	0.000181	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NPS—chronic kidney failure	2.66e-05	0.000181	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL5—chronic kidney failure	2.65e-05	0.00018	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CCR5—chronic kidney failure	2.64e-05	0.000179	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—EDN1—chronic kidney failure	2.63e-05	0.000179	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CCR5—chronic kidney failure	2.63e-05	0.000179	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGF23—chronic kidney failure	2.63e-05	0.000178	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—F2—chronic kidney failure	2.61e-05	0.000178	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL5—chronic kidney failure	2.61e-05	0.000177	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD1—chronic kidney failure	2.61e-05	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CCR5—chronic kidney failure	2.59e-05	0.000176	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.57e-05	0.000175	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—DDC—chronic kidney failure	2.57e-05	0.000174	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SREBF2—chronic kidney failure	2.54e-05	0.000172	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CYBA—chronic kidney failure	2.52e-05	0.000172	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NPY—chronic kidney failure	2.52e-05	0.000171	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NPY—chronic kidney failure	2.51e-05	0.000171	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2B6—chronic kidney failure	2.49e-05	0.000169	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PRKD1—chronic kidney failure	2.49e-05	0.000169	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PRKAG2—chronic kidney failure	2.49e-05	0.000169	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NPY—chronic kidney failure	2.47e-05	0.000168	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ACAT1—chronic kidney failure	2.46e-05	0.000167	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GCKR—chronic kidney failure	2.45e-05	0.000166	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCC3—chronic kidney failure	2.45e-05	0.000166	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—OXT—chronic kidney failure	2.43e-05	0.000165	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CRH—chronic kidney failure	2.43e-05	0.000165	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OXT—chronic kidney failure	2.42e-05	0.000165	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CRH—chronic kidney failure	2.42e-05	0.000165	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCR5—chronic kidney failure	2.4e-05	0.000163	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPIN1—chronic kidney failure	2.4e-05	0.000163	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCR5—chronic kidney failure	2.39e-05	0.000162	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OXT—chronic kidney failure	2.38e-05	0.000162	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CRH—chronic kidney failure	2.38e-05	0.000162	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—POMC—chronic kidney failure	2.38e-05	0.000162	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—F2—chronic kidney failure	2.37e-05	0.000161	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.36e-05	0.00016	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCR5—chronic kidney failure	2.35e-05	0.00016	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2C18—chronic kidney failure	2.35e-05	0.000159	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LRP2—chronic kidney failure	2.35e-05	0.000159	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SREBF2—chronic kidney failure	2.33e-05	0.000158	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NCF1—chronic kidney failure	2.33e-05	0.000158	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NCF1—chronic kidney failure	2.32e-05	0.000158	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NPS—chronic kidney failure	2.3e-05	0.000156	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NPS—chronic kidney failure	2.3e-05	0.000156	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	2.29e-05	0.000155	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NCF1—chronic kidney failure	2.28e-05	0.000155	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—F2—chronic kidney failure	2.26e-05	0.000154	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NPS—chronic kidney failure	2.26e-05	0.000154	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD1—chronic kidney failure	2.26e-05	0.000153	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—F2—chronic kidney failure	2.26e-05	0.000153	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCC3—chronic kidney failure	2.25e-05	0.000153	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GCKR—chronic kidney failure	2.25e-05	0.000153	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD1—chronic kidney failure	2.25e-05	0.000153	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—F2—chronic kidney failure	2.22e-05	0.000151	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HBEGF—chronic kidney failure	2.22e-05	0.000151	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD1—chronic kidney failure	2.22e-05	0.000151	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPIN1—chronic kidney failure	2.2e-05	0.00015	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CYBA—chronic kidney failure	2.19e-05	0.000149	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CYBA—chronic kidney failure	2.18e-05	0.000148	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—POMC—chronic kidney failure	2.16e-05	0.000147	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2C18—chronic kidney failure	2.16e-05	0.000147	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LRP2—chronic kidney failure	2.16e-05	0.000147	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CYBA—chronic kidney failure	2.15e-05	0.000146	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCL2—chronic kidney failure	2.12e-05	0.000144	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	2.09e-05	0.000142	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—chronic kidney failure	2.06e-05	0.00014	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—F2—chronic kidney failure	2.06e-05	0.00014	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—chronic kidney failure	2.06e-05	0.00014	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—F2—chronic kidney failure	2.05e-05	0.000139	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—chronic kidney failure	2.02e-05	0.000138	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—F2—chronic kidney failure	2.02e-05	0.000137	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CPT1A—chronic kidney failure	2e-05	0.000136	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LIPC—chronic kidney failure	1.95e-05	0.000132	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCG1—chronic kidney failure	1.94e-05	0.000132	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AVP—chronic kidney failure	1.92e-05	0.000131	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HBEGF—chronic kidney failure	1.92e-05	0.00013	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.92e-05	0.00013	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HBEGF—chronic kidney failure	1.91e-05	0.00013	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	1.9e-05	0.000129	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HBEGF—chronic kidney failure	1.88e-05	0.000128	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—chronic kidney failure	1.87e-05	0.000127	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—chronic kidney failure	1.87e-05	0.000127	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ARG2—chronic kidney failure	1.86e-05	0.000127	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—chronic kidney failure	1.84e-05	0.000125	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CPT1A—chronic kidney failure	1.84e-05	0.000125	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL2—chronic kidney failure	1.83e-05	0.000125	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EDN1—chronic kidney failure	1.83e-05	0.000124	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL2—chronic kidney failure	1.83e-05	0.000124	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LCAT—chronic kidney failure	1.83e-05	0.000124	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL5—chronic kidney failure	1.81e-05	0.000123	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL2—chronic kidney failure	1.8e-05	0.000122	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SCARB1—chronic kidney failure	1.8e-05	0.000122	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LIPC—chronic kidney failure	1.79e-05	0.000122	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	1.79e-05	0.000122	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS1—chronic kidney failure	1.78e-05	0.000121	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LPL—chronic kidney failure	1.77e-05	0.00012	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.75e-05	0.000119	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SREBF1—chronic kidney failure	1.75e-05	0.000119	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMGCR—chronic kidney failure	1.7e-05	0.000115	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NGF—chronic kidney failure	1.68e-05	0.000114	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DDC—chronic kidney failure	1.68e-05	0.000114	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AVP—chronic kidney failure	1.67e-05	0.000113	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—FASN—chronic kidney failure	1.66e-05	0.000113	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AVP—chronic kidney failure	1.66e-05	0.000113	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SCARB1—chronic kidney failure	1.65e-05	0.000112	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS1—chronic kidney failure	1.64e-05	0.000111	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AVP—chronic kidney failure	1.63e-05	0.000111	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR5—chronic kidney failure	1.63e-05	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.63e-05	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.63e-05	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.63e-05	0.000111	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SREBF1—chronic kidney failure	1.61e-05	0.000109	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EDN1—chronic kidney failure	1.58e-05	0.000108	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EDN1—chronic kidney failure	1.58e-05	0.000107	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL5—chronic kidney failure	1.57e-05	0.000107	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL5—chronic kidney failure	1.57e-05	0.000106	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMGCR—chronic kidney failure	1.56e-05	0.000106	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EDN1—chronic kidney failure	1.55e-05	0.000106	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL5—chronic kidney failure	1.54e-05	0.000105	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP3A4—chronic kidney failure	1.54e-05	0.000105	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LPL—chronic kidney failure	1.54e-05	0.000104	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LPL—chronic kidney failure	1.53e-05	0.000104	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.53e-05	0.000104	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—FASN—chronic kidney failure	1.53e-05	0.000104	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.52e-05	0.000104	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCA1—chronic kidney failure	1.51e-05	0.000103	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LPL—chronic kidney failure	1.51e-05	0.000102	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.47e-05	0.0001	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.47e-05	0.0001	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NGF—chronic kidney failure	1.46e-05	9.89e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NGF—chronic kidney failure	1.45e-05	9.86e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.44e-05	9.79e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NGF—chronic kidney failure	1.43e-05	9.7e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR5—chronic kidney failure	1.42e-05	9.62e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	1.42e-05	9.62e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.41e-05	9.59e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.41e-05	9.59e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR5—chronic kidney failure	1.41e-05	9.59e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—F2—chronic kidney failure	1.4e-05	9.52e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCA1—chronic kidney failure	1.39e-05	9.45e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR5—chronic kidney failure	1.39e-05	9.44e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS1—chronic kidney failure	1.33e-05	9.01e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAT—chronic kidney failure	1.28e-05	8.7e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—chronic kidney failure	1.28e-05	8.68e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—chronic kidney failure	1.25e-05	8.49e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCB1—chronic kidney failure	1.25e-05	8.46e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—chronic kidney failure	1.23e-05	8.35e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—F2—chronic kidney failure	1.21e-05	8.25e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—F2—chronic kidney failure	1.21e-05	8.23e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.2e-05	8.16e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—F2—chronic kidney failure	1.19e-05	8.1e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPL—chronic kidney failure	1.19e-05	8.06e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAT—chronic kidney failure	1.18e-05	8e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.17e-05	7.95e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.17e-05	7.95e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—chronic kidney failure	1.17e-05	7.92e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—KRAS—chronic kidney failure	1.15e-05	7.84e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS1—chronic kidney failure	1.15e-05	7.81e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP1A1—chronic kidney failure	1.15e-05	7.79e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCB1—chronic kidney failure	1.15e-05	7.78e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS1—chronic kidney failure	1.15e-05	7.78e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS1—chronic kidney failure	1.13e-05	7.66e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—chronic kidney failure	1.11e-05	7.57e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—chronic kidney failure	1.11e-05	7.52e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—chronic kidney failure	1.1e-05	7.49e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPL—chronic kidney failure	1.09e-05	7.42e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—chronic kidney failure	1.09e-05	7.38e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—chronic kidney failure	1.08e-05	7.36e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.08e-05	7.34e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—chronic kidney failure	1.08e-05	7.33e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.07e-05	7.27e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—chronic kidney failure	1.07e-05	7.26e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—chronic kidney failure	1.06e-05	7.23e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—chronic kidney failure	1.06e-05	7.22e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—chronic kidney failure	1.06e-05	7.21e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	1.05e-05	7.16e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.05e-05	7.13e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARA—chronic kidney failure	1.05e-05	7.12e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RELA—chronic kidney failure	1.05e-05	7.12e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—chronic kidney failure	1.04e-05	7.1e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.02e-05	6.93e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—chronic kidney failure	1.01e-05	6.87e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—chronic kidney failure	1.01e-05	6.84e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—KRAS—chronic kidney failure	1e-05	6.8e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FASN—chronic kidney failure	9.99e-06	6.79e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—KRAS—chronic kidney failure	9.98e-06	6.78e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—chronic kidney failure	9.92e-06	6.74e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—chronic kidney failure	9.83e-06	6.68e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—KRAS—chronic kidney failure	9.82e-06	6.67e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—chronic kidney failure	9.65e-06	6.56e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARA—chronic kidney failure	9.65e-06	6.55e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—chronic kidney failure	9.62e-06	6.54e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—chronic kidney failure	9.47e-06	6.43e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—chronic kidney failure	9.4e-06	6.38e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCA1—chronic kidney failure	9.1e-06	6.18e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RELA—chronic kidney failure	9.09e-06	6.17e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RELA—chronic kidney failure	9.06e-06	6.15e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RELA—chronic kidney failure	8.92e-06	6.06e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NFKB1—chronic kidney failure	8.84e-06	6.01e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—chronic kidney failure	8.55e-06	5.81e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—chronic kidney failure	8.14e-06	5.53e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—chronic kidney failure	8.12e-06	5.51e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—chronic kidney failure	8.02e-06	5.45e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—chronic kidney failure	7.99e-06	5.43e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—chronic kidney failure	7.86e-06	5.34e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—chronic kidney failure	7.79e-06	5.29e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAT—chronic kidney failure	7.7e-06	5.23e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NFKB1—chronic kidney failure	7.66e-06	5.2e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NFKB1—chronic kidney failure	7.64e-06	5.19e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NFKB1—chronic kidney failure	7.52e-06	5.11e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCB1—chronic kidney failure	7.49e-06	5.09e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—chronic kidney failure	7.46e-06	5.06e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—chronic kidney failure	7.37e-06	5e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—chronic kidney failure	7.17e-06	4.87e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPL—chronic kidney failure	7.14e-06	4.85e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—chronic kidney failure	6.95e-06	4.72e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—chronic kidney failure	6.93e-06	4.71e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	6.9e-06	4.68e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—chronic kidney failure	6.86e-06	4.66e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—chronic kidney failure	6.82e-06	4.63e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KRAS—chronic kidney failure	6.82e-06	4.63e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—chronic kidney failure	6.82e-06	4.63e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—chronic kidney failure	6.43e-06	4.37e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—chronic kidney failure	6.38e-06	4.34e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—chronic kidney failure	6.36e-06	4.32e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARA—chronic kidney failure	6.31e-06	4.28e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—chronic kidney failure	6.27e-06	4.26e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—chronic kidney failure	6.26e-06	4.25e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KRAS—chronic kidney failure	5.91e-06	4.02e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KRAS—chronic kidney failure	5.89e-06	4e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KRAS—chronic kidney failure	5.8e-06	3.94e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—chronic kidney failure	5.55e-06	3.77e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—chronic kidney failure	5.14e-06	3.49e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—chronic kidney failure	4.81e-06	3.27e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—chronic kidney failure	4.79e-06	3.26e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—chronic kidney failure	4.72e-06	3.21e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—chronic kidney failure	4.69e-06	3.18e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—chronic kidney failure	4.48e-06	3.05e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—chronic kidney failure	4.1e-06	2.79e-05	CbGpPWpGaD
